Narciclasine exerts anti-inflammatory actions by blocking leukocyte-endothelial cell interactions and down-regulation of the endothelial TNF receptor 1.
Stark A, Schwenk R, Wack G, Zuchtriegel G, Hatemler MG, Bräutigam J, Schmidtko A, Reichel CA, Bischoff I, Fürst R.
Stark A, et al. Among authors: furst r.
FASEB J. 2019 Aug;33(8):8771-8781. doi: 10.1096/fj.201802440R. Epub 2019 Apr 24.
FASEB J. 2019.
PMID: 31017817
Most importantly, we showed that the observed inhibitory action of narciclasine on TNF-triggered signaling pathways is based on the loss of TNFR1.-Stark, A., Schwenk, R., Wack, G., Zuchtriegel, G., Hatemler, M. G., Brautigam, J., Schmidtko, A., Reichel, C. A., Bischoff, I. …
Most importantly, we showed that the observed inhibitory action of narciclasine on TNF-triggered signaling pathways is based on the loss of …